Epigenetic changes within the promoter region of the HLA-G gene in ovarian tumors

Table 4 Patient samples analyzed in this study

Patient	Histology	Age	FIGO Stage	Grade
228	Clear cell adenocarcinoma	55	Ia	N/A
317	Serous papillary adenocarcinoma	59	Ic	3
170	Mixed endometrioid/serous papillary adenocarcinoma	57	IIa	2
413	Serous papillary adenocarcinoma	50	IIb	3
212	Mixed endometrioid/serous papillary adenocarcinoma	59	IIIc	3
369	Serous papillary adenocarcinoma	52	IIIc	3
242	Serous papillary adenocarcinoma	64	IIIc	3
229	Serous papillary adenocarcinoma	58	IIIc	3
183	Serous papillary adenocarcinoma	66	IIIc	2
412	Mucinous cystadenoma	65
377	Mucinous cystadenoma	42
383	Mucinous cystadenoma with focal borderline features	75
382	Serous cystadenofibroma	67
386	Serous cystadenofibroma	59
388	Serous cystadenofibroma	53
371	Serous cystadenofibroma	60
400	Serous cystadenofibroma	43
416	Serous cystadenoma	65
492	Normal surface epithelium	38
499	Normal surface epithelium	69
500	Normal surface epithelium	25
525	Normal surface epithelium	70

ISSN: 1476-4598